Cambridge Cognition Acquires Winterlight Labs

Cambridge Cognition, a developer of digital solutions to assess patients' brain health, has acquired Winterlight Labs, a provider of speech-based biomarker technology, for roughly $8.58 million.

Winterlight Labs was spawned from the computational linguistics department at the University of Toronto.

With the acquisition, Cambridge Cognition is adding to its portfolio of screen-based cognitive assessments and structured voice-based cognitive assessments. Its voice capabilities thus far have been limited to replicating structured one- or two-word verbal assessments.

"Having developed short speech-based cognitive assessments for several years, we have seen the considerable potential for longer free-speech assessments," said Matthew Stork, CEO of Cambridge Cognition, in a statement.

"Winterlight has established itself as a leader in monitoring cognitive impairment through free-speech analysis," Stork continued. "We look forward to welcoming our new colleagues at Winterlight so that together we can build on our combined expertise in voice technology to drive innovation in clinical trials."